TAUNS Laboratories,Inc. (TYO:197A)

Japan · Delayed Price · Currency is JPY

528.00

+1.00 (0.19%)

Sep 25, 2026, 3:30 PM JST

Market Cap	56.38B -3.8%
Revenue (ttm)	14.37B -22.9%
Net Income	5.50B -13.0%
EPS	51.08 -13.3%
Shares Out	106.78M
PE Ratio	10.34
Forward PE	15.64
Dividend	29.00 (5.49%)
Ex-Dividend Date	Jun 29, 2026

Volume	226,900
Open	529.00
Previous Close	527.00
Day's Range	525.00 - 534.00
52-Week Range	463.00 - 577.00
Beta	0.73
Analysts	Sell
Price Target	420.00 (-20.45%)
Est. Earnings	Nov 13, 2026

About TAUNS Laboratories,Inc.

TAUNS Laboratories,Inc. engages in the development, manufacture, export/import, and sale of in vitro diagnostics and research reagents, and its intermediates in Japan and internationally. The company also offers medical physicochemical measuring equipment, industrial measuring equipment, and medical devices; and contract research services. The company was founded in 1987 and is headquartered in Izunokuni, Japan. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1987

Employees 218

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 197A

Full Company Profile

Financial Performance

In fiscal year 2026, TAUNS Laboratories,Inc.'s revenue was 14.37 billion, a decrease of -22.86% compared to the previous year's 18.63 billion. Earnings were 5.50 billion, a decrease of -12.99%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 197A stock is "Sell." The 12-month stock price target is ¥420, which is a decrease of -20.45% from the latest price.

Price Target

¥420

(-20.45% downside)

Analyst Consensus: Sell

Stock Forecasts